Pacific Biosciences Of California (PACB) EPS (Basic) (QoQ) (2010 - 2026)
Powered by 
Analysis
Pacific Biosciences Of California (PACB) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.12 Bn | 221.06 Bn | 8.34 Bn |
| 2 | Danaher | 144.34 Bn | 139.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 41.01 Bn | 39.25 Bn | 1.04 Bn |
| 4 | Illumina | 31.14 Bn | 29.97 Bn | 770.00 Mn |
| 5 | Revvity | 13.89 Bn | 12.86 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.13 Bn | 8.51 Bn | 345.80 Mn |
| 8 | Repligen | 9.34 Bn | 8.33 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.67 Bn | 8.12 Bn | 112.50 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -432.26% |
| Mar 31, 2026 | 79.90% |
| Dec 31, 2025 | -6.55% |
| Sep 30, 2025 | 9.58% |
| Jun 30, 2025 | 90.27% |
| Mar 31, 2025 | -16,716.10% |
| Dec 31, 2024 | 103.88% |
| Sep 30, 2024 | 65.03% |
| Jun 30, 2024 | -119.41% |
| Mar 31, 2024 | 10.32% |
| Dec 31, 2023 | -23.32% |
| Sep 30, 2023 | 6.10% |
| Jun 30, 2023 | 23.21% |
| Mar 31, 2023 | 3.23% |
| Dec 31, 2022 | -9.91% |
| Sep 30, 2022 | -7.51% |
| Jun 30, 2022 | 13.26% |
| Mar 31, 2022 | -7.95% |
| Jun 30, 2021 | -13.75% |
| Mar 31, 2021 | -140.17% |